We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
–
AUM
$151M
AUM Growth
-$4.77M
Cap. Flow
+$6.61M
Cap. Flow %
4.38%
Top 10 Hldgs %
51.89%
Holding
243
New
14
Increased
48
Reduced
40
Closed
18

Top Buys

Rank Stock Value
1
HYMB icon
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
+$3.04M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$2.2M
3
IFGL icon
iShares International Developed Real Estate ETF
IFGL
+$893K
4
FDLO icon
Fidelity Low Volatility Factor ETF
FDLO
+$872K
5
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$853K

Top Sells

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.07M
2
VNQI icon
Vanguard Global ex-US Real Estate ETF
VNQI
+$825K
3
VWOB icon
Vanguard Emerging Markets Government Bond ETF
VWOB
+$799K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$488K
5
FCAL icon
First Trust California Municipal High income ETF
FCAL
+$484K

Sector Composition

Rank Sector Weight
1 Technology 3.41%
2 Financials 2.26%
3 Communication Services 1.85%
4 Healthcare 1.09%
5 Consumer Discretionary 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRTS
176
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$26K 0.02%
10,000
– –
PBYI icon
177
Puma Biotechnology
PBYI
$404M
$24K 0.02%
10,000
– –
VCLT icon
178
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$24K 0.02%
326
– –
BWZ icon
179
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$269M
$23K 0.02%
903
– –
AMRX icon
180
Amneal Pharmaceuticals
AMRX
$5.85B
$20K 0.01%
10,000
– –
AMRN
181
Amarin Corp
AMRN
$299M
$18K 0.01%
805
– –
INO icon
182
Inovio Pharmaceuticals
INO
$55.7M
$17K 0.01%
833
– –
IWR icon
183
iShares Russell Mid-Cap ETF
IWR
$56B
$17K 0.01%
268
– –
RPG icon
184
Invesco S&P 500 Pure Growth ETF
RPG
$2.01B
$17K 0.01%
600
– –
ASMB icon
185
Assembly Biosciences
ASMB
$498M
$16K 0.01%
833
– –
IRON icon
186
Disc Medicine
IRON
$2.96B
$16K 0.01%
333
– –
JIG icon
187
JPMorgan International Growth ETF
JIG
$471M
$16K 0.01%
347
-285
-45% -$15K
XERS icon
188
Xeris Biopharma Holdings
XERS
$1.39B
$16K 0.01%
10,000
– –
SRNE
189
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$16K 0.01%
10,000
– –
AXDX
190
DELISTED
Accelerate Diagnostics
AXDX
$15K 0.01%
1,000
– –
ADVM
191
DELISTED
Adverum Biotechnologies
ADVM
$14K 0.01%
1,500
– –
VYM icon
192
Vanguard High Dividend Yield ETF
VYM
$80.9B
$14K 0.01%
+150
New +$15.6K
AQST icon
193
Aquestive Therapeutics
AQST
$463M
$12K 0.01%
10,000
– –
VB icon
194
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$12K 0.01%
70
– –
VTV icon
195
Vanguard Morningstar Value ETF
VTV
$188B
$12K 0.01%
100
– –
CLVS
196
DELISTED
Clovis Oncology, Inc.
CLVS
$12K 0.01%
10,000
– –
ADAP
197
DELISTED
Adaptimmune Therapeutics
ADAP
$11K 0.01%
10,000
– –
DHC
198
Diversified Healthcare Trust
DHC
$2.15B
$10K 0.01%
10,000
– –
IWN icon
199
iShares Russell 2000 Value ETF
IWN
$14.3B
$10K 0.01%
80
– –
REZ icon
200
iShares Residential and Multisector Real Estate ETF
REZ
$879M
$10K 0.01%
146
– –
6 7
8
9 10

Similar funds

PWM
Platform Wealth Management Holladay, Utah $376M AUM
RC
Rovin Capital Mesa, Arizona $377M AUM 13.67% 1-Year Est. Return
EP
EnCap Partners Houston, Texas $383M AUM 10.44% 1-Year Est. Return
MWM
MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return
LODC
Lanham O'Dell & Company Hurricane, West Virginia $347M AUM 20.92% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
SHFA
SS&H Financial Advisors Troy, Michigan $343M AUM 28.43% 1-Year Est. Return
DP
Divergent Planning Bethesda, Maryland $392M AUM 13.55% 1-Year Est. Return

Running Point Capital Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Running Point Capital Advisors held 243 positions worth $151M, down 3.1% from $156M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Running Point Capital Advisors deployed $6.61M of net new capital in Q3 2022, opening 14 new positions and adding to 48 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 56,382 shares worth $1.97M.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $2.07M trimmed.

  • Running Point Capital Advisors's largest Q3 2022 buy was iShares MSCI Emerging Markets ETF: 56,382 shares worth $1.97M.
  • Running Point Capital Advisors added most to State Street SPDR Nuveen ICE High Yield Municipal Bond ETF in Q3 2022, an estimated $3.04M increase.
  • Running Point Capital Advisors's biggest Q3 2022 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $2.07M.
  • Running Point Capital Advisors fully exited Boeing in Q3 2022, selling an estimated $404K.
  • Running Point Capital Advisors's ten largest holdings make up 52% of its $151M portfolio in Q3 2022.
  • Running Point Capital Advisors opened 14 new positions and closed 18 in Q3 2022.
  • Running Point Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $151M.

Based on Running Point Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.